{"id":642709,"date":"2017-08-21T04:04:51","date_gmt":"2017-08-21T04:04:51","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/"},"modified":"2017-08-21T04:04:51","modified_gmt":"2017-08-21T04:04:51","slug":"hikma-gets-unwanted-attention-for-us-price-hikes","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/","title":{"rendered":"Hikma gets unwanted attention for US price hikes"},"content":{"rendered":"

<\/a> REGIONAL\u2013 Not the type of attention you want in the international press:<\/strong> Hikma is indeed London-listed, but the Jordan-based maker of meds is one of the quietest global success stories to have emerged from our corner of the world. Now, the company is under fire after a Financial Times investigation<\/a> found that it had \u201csharply increased the price of a string of medicines in the US \u2014 including a \u2026 treatment that has risen 430 per cent \u2014 in the latest instance of \u2018gouging\u2019.\u201d <\/strong>Reuters has picked up the FT\u2019s piece<\/a>, making sure it goes global. Couple this with the newspaper\u2019s earlier commentary on below-expectation results in 1H2017<\/a> and it\u2019s simple enough to paint this as a case of corporate avarice.<\/p>\n","protected":false},"excerpt":{"rendered":"

REGIONAL\u2013 Not the type of attention you want in the international press: Hikma is indeed London-listed, but the Jordan-based maker of meds is one of the quietest global success stories to have emerged from our corner of the world. Now, the company is under fire after a Financial Times investigation found that it had \u201csharply […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-642709","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"a81f1b63-359f-4923-80a2-6d1e6b9f85a7","order":"0","is_powered_by":true,"section_story_id":"d99acbc1-f259-431e-b1f2-6f6bcbdbf5c0","story_type":"1","photo_url":"","photo_position":"above","related_issue":[642693],"teaser":"","voice_url":""},"yoast_head":"\nHikma gets unwanted attention for US price hikes - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hikma gets unwanted attention for US price hikes\" \/>\n<meta property=\"og:description\" content=\"REGIONAL\u2013 Not the type of attention you want in the international press: Hikma is indeed London-listed, but the Jordan-based maker of meds is one of the quietest global success stories to have emerged from our corner of the world. Now, the company is under fire after a Financial Times investigation found that it had \u201csharply […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-21T04:04:51+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Hikma gets unwanted attention for US price hikes\",\"datePublished\":\"2017-08-21T04:04:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/\"},\"wordCount\":128,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/\",\"name\":\"Hikma gets unwanted attention for US price hikes - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2017-08-21T04:04:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hikma gets unwanted attention for US price hikes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hikma gets unwanted attention for US price hikes - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/","og_locale":"en_US","og_type":"article","og_title":"Hikma gets unwanted attention for US price hikes","og_description":"REGIONAL\u2013 Not the type of attention you want in the international press: Hikma is indeed London-listed, but the Jordan-based maker of meds is one of the quietest global success stories to have emerged from our corner of the world. Now, the company is under fire after a Financial Times investigation found that it had \u201csharply […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2017-08-21T04:04:51+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Hikma gets unwanted attention for US price hikes","datePublished":"2017-08-21T04:04:51+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/"},"wordCount":128,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/","url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/","name":"Hikma gets unwanted attention for US price hikes - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2017-08-21T04:04:51+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Hikma gets unwanted attention for US price hikes"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":642650,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/","url_meta":{"origin":642709,"position":0},"title":"Hikma signs agreement to sell Takeda\u2019s primary care products regionally","author":"enterpriseam admin","date":"20 August 2017","format":false,"excerpt":"REGIONAL- Jordanian med manufacturer Hikma signed an agreement with Takeda to expand licensing and distribution. The agreement allows Hikma to have the right to register, manufacture, market, distribute, and sell four of Takeda's leading primary care products in 17 markets in the MENA region. \u201cThe agreement, however, does not include\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":645639,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/26\/eaef-looks-to-buy-orchidia-pharma\/","url_meta":{"origin":642709,"position":1},"title":"EAEF looks to buy Orchidia Pharma","author":"enterpriseam admin","date":"26 July 2017","format":false,"excerpt":"M&A WATCH- Our friends at the Egyptian American Enterprise Fund (EAEF) are reportedly planning to invest in Orchidia Pharma, sources close to the matter tell Al Borsa. While EAEF is hoping to acquire up to 100% of the company, it would settle on a majority stake of 55%, the sources\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":565019,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-is-staying-put-for-now\/","url_meta":{"origin":642709,"position":2},"title":"GSK is staying put \u2014 for now","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"GSK puts Egypt exit on the backburner: GlaxoSmithKline has shelved plans to sell its units in Egypt and Tunisia following the breakdown of talks with UK-listed Hikma Pharma, the company said in a disclosure (pdf) to the EGX today. The pharma giant initially wanted to sell its entire 91.2% stake\u2026","rel":"","context":"In "SPEED ROUND: M&A WATCH"","block_context":{"text":"SPEED ROUND: M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round-ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":639560,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/10\/31\/new-ras-al-hikma-city-in-the-works\/","url_meta":{"origin":642709,"position":3},"title":"New Ras Al Hikma City in the works","author":"enterpriseam admin","date":"31 October 2017","format":false,"excerpt":"The government is looking to build a New Ras Al Hikma City on the North Coast,sources tell Al Borsa. The 150 mn sqm city will be centered on tourism and is intended to complement the new Al Alamein City. Planned projects include resorts and an international marina to serve the\u2026","rel":"","context":"In "Tourism"","block_context":{"text":"Tourism","link":"https:\/\/enterpriseam.com\/egypt\/category\/data\/tourism\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":560791,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","url_meta":{"origin":642709,"position":4},"title":"GSK, Hikma end acquisition talks","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"Hikma Pharma won\u2019t be acquiring GlaxoSmithKline\u2019s Egypt unit: GSK and Hikma Pharma have agreed to end talks over a takeover bid submitted in January by the UK-listed company that would have seen it acquire a majority stake in GSK\u2019s Egypt arm, both companies said (here and here \u2013 pdfs) on\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":559722,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/02\/a-bidding-war-for-gsks-egyptian-arm\/","url_meta":{"origin":642709,"position":5},"title":"A bidding war for GSK\u2019s Egyptian arm?","author":"enterpriseam admin","date":"2 February 2021","format":false,"excerpt":"Acdima may have just touched off a bidding war for GlaxoSmithKline's Egypt business, according to a regulatory filing (pdf) yesterday, less than a week after the global player revealed that Hikma was interested in a transaction. Acdima, a pharma industry investor focused on Arab countries, plans to make an offer\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/37.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/642709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=642709"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/642709\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/642693"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=642709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=642709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=642709"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=642709"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=642709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}